- $30.90m
- $31.35m
- $86.21m
Annual income statement for Inuvo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 59.8 | 75.6 | 73.9 | 83.8 | 86.2 |
| Cost of Revenue | |||||
| Gross Profit | 43.9 | 45.4 | 63.4 | 71.8 | 64.2 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 67.6 | 88.3 | 84.3 | 89.3 | 92.9 |
| Operating Profit | -7.77 | -12.6 | -10.4 | -5.51 | -6.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.6 | -13.1 | -10.4 | -5.75 | -5.08 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.6 | -13.1 | -10.4 | -5.76 | -5.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.6 | -13.1 | -10.4 | -5.76 | -5.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.6 | -13.1 | -10.4 | -5.76 | -5.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.646 | -1.09 | -0.792 | -0.412 | -0.352 |